Optimization of an Erythroid Culture System to Reduce the Cost of in vitro Production of Red Blood Cells

Saiphon Poldee, Chanatip Metheetrairuta, Sutthinee Nugoolsuksiri, Jan Frayne, Tom Trakarnsanga

Research output: Contribution to journalArticle (Academic Journal)peer-review

4 Citations (Scopus)
230 Downloads (Pure)


In vitro generation of red blood cells has become a goal for scientists globally. Directly, in vitro-generated red blood cells (RBCs) may close the gap between blood supply obtained through blood donation and high demand for therapeutic uses. In addition, the cells obtained can be used as a model for haematologic disorders to allow the study of their pathophysiology and novel treatment discovery. For those reasons, a number of RBC culture systems have been established and shown to be successful; however, the cost of each millilitre of packed RBC is still extremely high. In order to reduce the cost, we aim to see if we can reduce the number of factors used in the existing culture system. In this study, we examined how well haematopoietic stem cells proliferate and differentiate into mature red blood cells with modified culture system.

• Absence of extra heparin or insulin or both from the erythroid differentiation media did not affect haematopoietic stem cell proliferation and differentiation.

Therefore, we show that the cost and complexity of erythroid culture can be reduced, which may improve the feasibility of in vitro generation of red blood cells.
Original languageEnglish
Pages (from-to)1626-1632
Number of pages7
Early online date30 Nov 2018
Publication statusPublished - 2018


Dive into the research topics of 'Optimization of an Erythroid Culture System to Reduce the Cost of in vitro Production of Red Blood Cells'. Together they form a unique fingerprint.

Cite this